🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Wan‐Jen Hong

Mission Bio (United States)

ORCID: 0000-0002-0134-4927

Also affiliated with Interdisciplinary Dental Education Academy, Guangdong 999 Brain Hospital

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Venetoclax or placebo in combination with bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (BELLINI): a randomised, double-blind, multicentre, phase 3 trial”.

Venetoclax or placebo in combination with bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (BELLINI): a randomised, double-blind, multicentre, phase 3 trial

The Lancet Oncology(2020)10.1016/s1470-2045(20)30525-8

N/A

5.3DataRank · unranked

407 citations

Simon J. Harrison, Michèle Cavo, Javier de la Rubia, Rakesh Popat, Cristina Gasparetto +15 more

NOT-Gated CD93 CAR T Cells Effectively Target AML with Minimized Endothelial Cross-Reactivity

Blood Cancer Discovery(2021)10.1158/2643-3230.bcd-20-0208

N/A

0DataRank · unranked

93 citations

Feifei Zhao, Katherine A. Freitas, Kevin R. Parker, Peng Xu, Amy C. Fan +12 more

Phase Ib study of PRT543, an oral protein arginine methyltransferase 5 (PRMT5) inhibitor, in patients with advanced splicing factor-mutant myeloid malignancies

Leukemia(2025)10.1038/s41375-025-02515-8

N/A

0DataRank · unranked

13 citations

Xiaoli Mi, Bin Lü, Andrew Kuykendall, David A. Sallman, Manish R. Patel +16 more